ORGANIC
LETTERS
2013
Vol. 15, No. 22
5778–5781
Creating Diversity by Site-Selective Peptide
Modification: A Customizable Unit Affords
Amino Acids with High Optical Purity
Ivan Romero-Estudillo and Alicia Boto*
´ ´
Instituto de Productos Naturales y Agrobiologıa del CSIC, Avda. Astrofısico Fco.
ꢀ
Sanchez, 3, 38206-La Laguna, Tenerife, Spain
Received September 28, 2013
ABSTRACT
The development of peptide libraries by site-selective modification of a few parent peptides would save valuable time and materials in discovery
processes, but still is a difficult synthetic challenge. Herein natural hydroxyproline is introduced as a “convertible” unit for the production of a variety
of optically pure amino acids, including expensive N-alkyl amino acids, and to achieve the mild, efficient, and site-selective modification of peptides.
The modification of peptides has elicited much interest,
in order to provide new peptide drugs,1 probes for mole-
cular imaging,2 and peptide catalysts for green chemistry.3
During the discovery process of bioactive or catalytic
peptides, libraries of analogues of a lead compound are
prepared. Their activities are studied next, in order to
determine structureꢀactivity relationships and then design
new generations of modified peptides.
In the traditional approach to obtain these peptides,
each compound is synthesized de novo; in each case, a
modification with respect to the parent peptide is intro-
duced.1ꢀ3 This serial procedure is costly in time and
materials. When the peptides are particularly difficult to
obtain (e.g., long or difficult sequences, macrocycles) or
when only part of the peptide requires modification, a site-
selective transformation would be preferable.4,5 In this
alternative strategy, a single (or a few) starting peptide is
used to generate the other library members, by selective
conversion of a “customizable” (or “tunable”) residue.
This strategy has recently attracted much attention in
academia and industry, and customizable units such as
glycine, dehydroalanine, 4-azidoproline, allylglycine, cy-
steine, and aziridine carboxylic acids have been reported6ꢀ8
and used for the selective modification of small peptides.7,8
(5) (a) For the “Tag-and-Modify” approach to protein modification,
see: Chalker, J. M.; Bernardes, G. J. L.; Davis, B. G. Acc. Chem. Res.
2011, 44, 730ꢀ741. (b) See also: Takaoka, Y.; Ojida, A.; Hamachi, I.
Angew. Chem., Int. Ed. 2013, 52, 4088–4106. (c) Dıaz-Rodrıguez, A.;
ꢀ
Davis, B. G. Curr. Opin. Chem. Biol. 2011, 15, 211–219. (d) Basle, E.;
(1) (a) Sewald, N.; Jakubke, H. D. Peptides: Chemistry and Biology;
Wiley-VCH: Weinheim, 2002. (b) Handbook of Biologically Active Pep-
tides; Kastin, A. J., Ed.; Academic Press: San Diego, 2006. (c) Acc. Chem.
Res. 2008, 41, no. 10, Special Issue on Peptidomimetics.
Joubert, N.; Pucheault, M. Chem. Biol. 2010, 17, 213–227. (e) Rabuka,
D. Curr. Opin. Chem. Biol. 2010, 14, 790–796. (f) Ostresh, J. M.; Husar,
G. M.; Blondelle, S. E.; Dorner, B.; Webert, P. A.; Houghten, R. A.
€
Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 11138–11142.
(2) Lee, S.; Xie, J.; Chen, X. Chem. Rev. 2010, 110, 3087–3111 and
references cited therein.
(6) (a) Seebach, D.; Bech, A. K.; Studer, A. Modern Synthetic
Methods, Vol. 7; Ernst, B., Leumann, C., Eds.; VCH: Weinheim, 1995.
(b) Datta, S.; Kazmaier, U. Org. Biomol. Chem. 2011, 9, 872–880. (c)
Deska, J.; Kazmaier, U. Chem.;Eur. J. 2007, 13, 6204–6211. (d)
Erdmann, R. S.; Wennemers, H. J. Am. Chem. Soc. 2010, 132, 13957–
13959. (e) Franz, N.; Menin, L.; Klok, H. A. Org. Biomol. Chem. 2009, 7,
(3) (a) Freund, M.; Tsogoeva, S. B. Peptides for Asymmetric Cata-
lysis. In Catalytic Methods in Asymmetric Synthesis; Gruttadauria, M.,
Giacalone, F., Eds.; John Wiley and Sons: Hoboken, NJ, USA, 2011. (b)
Roelfes, G. ChemCatChem 2011, 3, 647–648. (c) Colby-Davie, E. A.;
Mennen, S. M.; Xu, Y.; Miller, S. J. Chem. Rev. 2007, 107, 5759–5812.
(4) (a) Ebran, J. P.; Jensen, C. M.; Johannesen, S. A.; Karaffa, J.;
Lindsay, K. B.; Taaning, R.; Skrydstrup, T. Org. Biomol. Chem. 2006, 4,
3553–3564. (b) Antos, J. M.; Francis, M. B. Curr. Opin. Chem. Biol.
2006, 10, 253–262. (c) Qi, D.; Tann, C. M.; Distefano, M. D. Chem. Rev.
2001, 101, 3081–3112.
ꢀ
5207–5218. (f) Galonic, D. P.; Ide, N. D.; van der Donk, W. A.; Gin,
ꢀ
D. Y. J. Am. Chem. Soc. 2005, 127, 7359–7369. (g) Galonic, D. P.;
van der Donk, W.; Gin, D. Y. J. Am. Chem. Soc. 2004, 126, 12712–
12713. (h) Dyer, F. B.; Park, C. M.; Joseph, R.; Garner, P. J. Am. Chem.
Soc. 2011, 133, 20033–20035. (i) Ricci, M.; Blakskjær, P.; Skrydstrup, T.
J. Am. Chem. Soc. 2000, 122, 1241–12421.
r
10.1021/ol402800a
Published on Web 10/30/2013
2013 American Chemical Society